Alberto Pavan

1.3k total citations
36 papers, 855 citations indexed

About

Alberto Pavan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Alberto Pavan has authored 36 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Alberto Pavan's work include Lung Cancer Treatments and Mutations (20 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Lung Cancer Research Studies (12 papers). Alberto Pavan is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Lung Cancer Research Studies (12 papers). Alberto Pavan collaborates with scholars based in Italy, United States and Austria. Alberto Pavan's co-authors include Pierfranco Conté, Giulia Pasello, Laura Bonanno, Valentina Guarneri, Ilaria Attili, Lorenzo Calvetti, Paola Del Bianco, Alessandro Dal Maso, Giuseppe Aprile and Stefano Indraccolo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Alberto Pavan

34 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Pavan Italy 14 591 432 186 174 138 36 855
Junxun Ma China 18 596 1.0× 373 0.9× 82 0.4× 124 0.7× 55 0.4× 45 796
Sara Elena Rebuzzi Italy 15 394 0.7× 331 0.8× 107 0.6× 117 0.7× 64 0.5× 67 643
Zhuoran Yao China 8 660 1.1× 220 0.5× 66 0.4× 133 0.8× 62 0.4× 19 817
Yasser Ged United States 12 212 0.4× 361 0.8× 169 0.9× 244 1.4× 60 0.4× 59 549
Giulia Mazzaschi Italy 11 444 0.8× 254 0.6× 96 0.5× 130 0.7× 29 0.2× 54 634
Lingdi Yin China 18 525 0.9× 187 0.4× 188 1.0× 179 1.0× 150 1.1× 39 749
Danilo Rocco Italy 17 537 0.9× 562 1.3× 386 2.1× 311 1.8× 47 0.3× 55 995
Thomas Grellety France 12 399 0.7× 274 0.6× 96 0.5× 113 0.6× 23 0.2× 42 613
Audrey Simonaggio France 10 445 0.8× 278 0.6× 51 0.3× 104 0.6× 45 0.3× 23 567
Sabrina Rossi Italy 19 611 1.0× 403 0.9× 181 1.0× 155 0.9× 36 0.3× 55 899

Countries citing papers authored by Alberto Pavan

Since Specialization
Citations

This map shows the geographic impact of Alberto Pavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Pavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Pavan more than expected).

Fields of papers citing papers by Alberto Pavan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Pavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Pavan. The network helps show where Alberto Pavan may publish in the future.

Co-authorship network of co-authors of Alberto Pavan

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Pavan. A scholar is included among the top collaborators of Alberto Pavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Pavan. Alberto Pavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pasello, Giulia, Alessandro Del Conte, Fabiana Letizia Cecere, et al.. (2024). Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World. The Oncologist. 29(7). 596–608. 2 indexed citations
3.
Bianco, Paola Del, Elisabetta Zulato, Ilaria Attili, et al.. (2024). Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer. npj Precision Oncology. 8(1). 234–234. 6 indexed citations
4.
Bonanno, Laura, Lorenzo Calvetti, Alessandro Dal Maso, et al.. (2024). Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis. Frontiers in Immunology. 15. 1353889–1353889. 3 indexed citations
5.
6.
Bonanno, Laura, Alessandro Dal Maso, Alberto Pavan, et al.. (2022). Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?. British Journal of Cancer. 127(3). 383–393. 54 indexed citations
7.
Pavan, Alberto, Alessandra Ferro, Francesco Fortarezza, et al.. (2022). Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome. The Oncologist. 27(2). e199–e202. 2 indexed citations
8.
Pavan, Alberto, Lorenzo Calvetti, Alessandra Ferro, et al.. (2021). Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome. Translational Lung Cancer Research. 10(1). 202–220. 37 indexed citations
9.
Ferro, Alessandra, Angela Filoni, Alberto Pavan, et al.. (2021). Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report. Frontiers in Medicine. 8. 570921–570921. 8 indexed citations
10.
Bonanno, Laura, Ilaria Attili, Alberto Pavan, et al.. (2021). Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practice. Critical Reviews in Oncology/Hematology. 163. 103378–103378. 14 indexed citations
11.
Bonanno, Laura, Alessandro Dal Maso, Alberto Pavan, et al.. (2021). 51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features. Journal of Thoracic Oncology. 16(4). S723–S724. 1 indexed citations
12.
Pasello, Giulia, Alberto Pavan, Ilaria Attili, et al.. (2020). Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer. Cancer Treatment Reviews. 87. 102031–102031. 91 indexed citations
13.
14.
Lohinai, Zoltán, Laura Bonanno, Alberto Pavan, et al.. (2019). Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer. PeerJ. 7. e7232–e7232. 27 indexed citations
15.
Pasello, Giulia, Giulia Zago, Francesca Lunardi, et al.. (2018). Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time. Annals of Oncology. 29(5). 1258–1265. 72 indexed citations
16.
Pavan, Alberto, Matteo Fassan, Maria Vittoria Dieci, et al.. (2018). 78O Immune microenvironment of small cell lung cancer (SCLC): Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumor infiltrating lymphocytes. Journal of Thoracic Oncology. 13(4). S43–S43.
17.
Bonanno, Laura, Alberto Pavan, Maria Vittoria Dieci, et al.. (2018). The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes. European Journal of Cancer. 101. 191–200. 83 indexed citations
18.
Bonanno, Laura, Elisabetta Zulato, Ilaria Attili, et al.. (2018). Liquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study. Annals of Oncology. 29. viii649–viii649. 5 indexed citations
19.
Macerelli, Marianna, Alessandro Del Conte, Laura Bonanno, et al.. (2017). Clinical features of never smoker patients with lung squamous cell carcinoma: a retrospective multicenter study. Annals of Oncology. 28. vi60–vi60. 1 indexed citations
20.
Attili, Ilaria, Antonio Passaro, Alberto Pavan, et al.. (2017). Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?. Critical Reviews in Oncology/Hematology. 119. 30–39. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junxun Ma Breakdown of academic impact, for papers by Sara Elena Rebuzzi Breakdown of academic impact, for papers by Zhuoran Yao Breakdown of academic impact, for papers by Yasser Ged Breakdown of academic impact, for papers by Giulia Mazzaschi Breakdown of academic impact, for papers by Lingdi Yin Breakdown of academic impact, for papers by Danilo Rocco Breakdown of academic impact, for papers by Thomas Grellety Breakdown of academic impact, for papers by Audrey Simonaggio Breakdown of academic impact, for papers by Sabrina Rossi
Rankless by CCL
2026